<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03504748</url>
  </required_header>
  <id_info>
    <org_study_id>VRBDCA</org_study_id>
    <nct_id>NCT03504748</nct_id>
  </id_info>
  <brief_title>Deep rTMS in Parkinson Disease Pain Syndromes</brief_title>
  <official_title>Deep rTMS in Parkinson Disease Pain Syndromes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain is the most prevalent non-motor symptom in Parkinson disease, and the motor improvement
      not always is related to the pain improvement with the medication treatment. By this, we are
      testing a non-invasive method called transcranial magnetic stimulation as an alternative to
      treat pain related to Parkinson disease. This technique can lead to either inhibitory or
      excitatory effects in brain circuits depending on stimulation parameters, and is known to
      provide analgesic effects.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 20, 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in baseline of Pain</measure>
    <time_frame>base line (moment of inclusion), day 15th, day 45th and in the last day of the sessions of rTMS (4X in two months)</time_frame>
    <description>assessing by Visual Analog Scale for Pain (VAS). This scale range from 0 (no pain) to 10 (maximum pain), being considered an effective improvement in the patient's pain when the pain decreases at least in 30% from the basal score.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pain</condition>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>deep rTMS-active doble coil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients undergoing of deep rTMS real with doble coil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>deep rTMS-sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>patients undergoing to placebo deep rTMS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>deep rTMS</intervention_name>
    <arm_group_label>deep rTMS-active doble coil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>placebo deep rTMS</intervention_name>
    <arm_group_label>deep rTMS-sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parkinson disease

          -  Signed term of informed consent

          -  Parkinsson disease related pain

        Exclusion Criteria:

          -  Trauma of Skull, epilepsy don't treated

          -  Use of medications decrease the seizure threshold

          -  Patients in use of drugs, how cocaine and alcohol

          -  neurosurgical clips, pacemakers, increased intracranial pressure (risk of sequelae
             after seizure)

          -  Pregnant or lacting women

          -  Moderate or severe cognitive impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Daniel MD Ciampi, Phd</last_name>
    <phone>+ 55 11 997753538</phone>
    <email>ciampi@usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Victor MD Barboza, PhD student</last_name>
    <phone>+ 55 11 997017706</phone>
    <email>victors.rb@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC/FMUSP)</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <zip>05403900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel MD Ciampi, Phd</last_name>
      <phone>+ 55 11 997753538</phone>
      <email>ciampi@usp.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>April 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2018</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Daniel Ciampi Araujo de Andrade, MD, PhD</investigator_full_name>
    <investigator_title>MD, PhD (Head of Pain Division)</investigator_title>
  </responsible_party>
  <keyword>deep repetitive transcranial magnetic stimulation</keyword>
  <keyword>chronic pain</keyword>
  <keyword>parkinson</keyword>
  <keyword>treatment</keyword>
  <keyword>non-motor symptom</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

